數位病理學市場－全球產業規模、佔有率、趨勢、機會和預測，按產品類型、應用、最終用戶、地區和競爭細分，2020-2030 年

2024 年全球數位病理學市場價值為 11.6 億美元，預計在預測期內將達到 22.3 億美元，到 2030 年的複合年成長率為 11.46%。數位病理學是一個專注於從數位化標本載玻片中提取資料的專業領域。透過利用基於電腦的技術和虛擬顯微鏡，數位病理學可以獲得基於影像的資訊。這種創新方法顯著提高了全球病理實驗室的效率、工作流程和收入。透過將載玻片轉換為數位副本，使用者可以在電腦顯示器上輕鬆管理、分享、檢視和分析它們。數位病理學可應用於各個領域，包括原發病診斷、診斷決策支援、術中診斷、診斷諮詢、住院醫師和醫生培訓、同行評審、手動和半定量免疫組織化學 (IHC) 審查以及臨床研究。它的實施提高了實驗室效率並加快了診斷結果。隨著教育部門、藥物開發、基於組織的研究和疾病診斷的支持不斷增加，數位病理學正迅速獲得認可，成為醫療保健領域必不可少且成熟的技術。

慢性病負擔日益加重，以及精準及時診斷的需求日益成長，是推動數位病理學應用的主要因素。隨著全球癌症、心血管疾病和傳染病發病率持續上升，醫療保健提供者正在尋求能夠簡化診斷流程並提高準確性的先進技術。數位病理學支援高解析度影像分析，並透過遠距訪問方便獲得第二診療意見，這在醫療資源匱乏的農村地區尤其有益。此功能不僅提高了診斷準確性，還縮短了周轉時間，從而加快了臨床決策速度，並改善了患者預後，尤其是在複雜或危重病例中。

關鍵市場促進因素

提高實驗室效率

主要市場挑戰

數位病理成本高昂

主要市場趨勢

遠距病理學和遠距會診

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球數位病理學市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 依產品類型（掃描器、軟體、儲存和通訊系統）
  • 按應用（疾病診斷、遠距會診、藥物研發、培訓和教育）
  • 按最終用戶（製藥和生物技術公司、醫院和診所、學術機構和研究實驗室）
  • 按地區
  • 按公司分類（2024）
• 市場地圖

第6章：北美數位病理學市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲數位病理學市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 德國
  • 英國
  • 義大利
  • 法國
  • 西班牙

第8章：亞太數字病理學市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：南美洲數位病理學市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第10章：中東和非洲數位病理學市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 近期發展
• 併購

第 13 章：全球數位病理學市場：SWOT 分析

第 14 章：競爭格局

• 3DHISTECH.
• Corista
• Aiforia Technologies Oy
• Akoya Biosciences
• OptraSCAN
• Glencoe Software
• QProscia Inc
• Kanteron Systems
• Mikroscan Technologies

第 15 章：策略建議

第16章調查會社について,免責事項

Global Digital Pathology Market was valued at USD 1.16 billion in 2024 and is expected to reach USD 2.23 billion in the forecast period with a CAGR of 11.46% through 2030. Digital pathology is a specialized field that focuses on extracting data from digitized specimen slides. By utilizing computer-based technology and virtual microscopy, digital pathology enables the acquisition of image-based information. This innovative approach has significantly enhanced the efficiency, workflow, and revenue of pathology labs worldwide. Through the conversion of glass slides into digital counterparts, users can effortlessly manage, share, view, and analyze them on a computer monitor. Digital pathology finds applications in various areas, including primary disease diagnosis, diagnostic decision support, intraoperative diagnosis, diagnostic consultation, resident and medical training, peer review, manual and semi-quantitative immunohistochemistry (IHC) review, and clinical research. Its implementation has led to improved laboratory efficiency and faster diagnostic results. With growing support from the education sector, drug development, tissue-based research, and disease diagnosis, digital pathology is rapidly gaining recognition as an essential and proven technology in the healthcare sector.

The increasing burden of chronic diseases and the growing demand for precise and timely diagnostics are major factors driving the adoption of digital pathology. As the global incidence of cancer, cardiovascular conditions, and infectious diseases continues to rise, healthcare providers are seeking advanced technologies that streamline diagnosis and improve accuracy. Digital pathology supports high-resolution image analysis and facilitates second opinions through remote access, which is particularly beneficial in underserved and rural regions. This capability not only enhances diagnostic accuracy but also reduces turnaround times, enabling faster clinical decision-making and better patient outcomes, especially in complex or critical cases.

Key Market Drivers

Enhanced Lab Efficiency

Digital pathology dramatically improves laboratory efficiency by accelerating image analysis and report turnaround. Recent data shows that slide review times have decreased by up to 40% after digital adoption, allowing pathologists to process more cases daily. Additionally, remote consultation speeds have improved by 50%, as specialists can collaborate in real time without physical slides. These efficiency gains not only alleviate workload but also shorten patient wait times for critical diagnostic results. With quicker access to digital slides, labs can streamline workflows, reduce bottlenecks, and improve overall operational performance in both clinical and research settings.

By enabling remote access to pathology images, digital platforms foster seamless collaboration among healthcare professionals. Specialists can review cases and consult across geographic locations instantly, eliminating delays tied to shipping and physical slide transfer. Studies show that 75% of pathologists report enhanced diagnostic confidence through virtual peer reviews. This collaborative environment promotes accurate diagnoses and accelerates treatment decisions-ultimately improving patient outcomes. As cross-functional teams, including oncologists and geneticists, access slides simultaneously, multidisciplinary care coordination is significantly enhanced, reinforcing the growing need for digital pathology in modern healthcare systems.

Another major advantage is cost reduction. Digital pathology eliminates phased costs associated with producing, storing, and transporting glass slides. For example, laboratories have reported up to 60% savings on shipping and archiving expenses. Storage facilities that once required extensive physical archive space are now replaced by secure digital repositories, reducing overhead. Additionally, digital retrieval systems enable rapid, on-demand access to historical slides, supporting longitudinal studies and clinical audits. This shift toward digital archives reduces operational complexity, enhances data integrity, and cuts total ownership costs-strengthening the case for digital investments.

Key Market Challenges

High Cost of Digital Pathology

The high cost of digital pathology and the low adoption rate in emerging and underdeveloped countries present obstacles to the market's growth. Augmenting addresses this challenge by offering a modular hardware platform with integrated digital pathology software applications, helping to keep costs low. Implementing digital pathology systems requires significant upfront investment in scanners, storage infrastructure, and software solutions. The expenses associated with digitizing slides, maintaining digital archives, and training personnel can be substantial, especially for small laboratories or healthcare facilities with limited budgets. Furthermore, integrating digital pathology into existing laboratory workflows and the need for IT support and infrastructure upgrades can pose challenges for some organizations.

Key Market Trends

Telepathology and Remote Consultation

The increasing adoption of telepathology enables remote diagnosis and consultation, allowing pathologists to collaborate and provide expert opinions without being limited by geographical constraints. Telepathology has gained significant prominence during the COVID-19 pandemic, as it facilitates remote working and minimizes the risk of exposure for pathologists. For instance, pathologists can remotely review and discuss cases with colleagues, participate in multidisciplinary tumor boards, or offer consultations to underserved areas or regions facing a shortage of pathology expertise. The increasing preference for computer-aided diagnosis, integrating image processing, physics, mathematics, and computing algorithms, facilitates efficient disease detection. It also assists in evaluating anatomic structures of interest, quantifying disease progression and risk assessment, thereby stimulating market growth. Notably, companies like Olympus offer a range of tools for remote slide sharing and image processing, contributing to anticipated market expansion in the upcoming years. In April 2020, Leica Biosystems obtained FDA approval for the Aperio AT2 DX Scanner and Aperio WebViewer, enabling remote diagnosis during the pandemic. Additionally, during this emergency, Phillips also received FDA approval for its IntelliSite Pathology Solution, further supporting remote diagnosis.

Key Market Players

• 3DHISTECH
• Corista
• Aiforia Technologies Oy
• Akoya Biosciences
• OptraSCAN
• Glencoe Software
• QProscia Inc
• Kanteron Systems
• Mikroscan Technologies

Report Scope:

In this report, the Global Digital Pathology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Digital Pathology Market, By Product Type:

• Scanners
• Software
• Storage & Communication Systems

Digital Pathology Market, By Application:

• Disease Diagnosis
• Teleconsultation
• Drug Discovery
• Training & Education

Digital Pathology Market, By End User:

• Pharmaceutical & Biotechnology Companies
• Hospitals and Clinics
• Academics Institutes & Research Laboratories

Digital Pathology Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Digital Pathology Market.

Available Customizations:

Global Digital Pathology market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Digital Pathology Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Scanners, Software, and Storage & Communication Systems)
  • 5.2.2. By Application (Disease Diagnosis, Teleconsultation, Drug Discovery, Training & Education)
  • 5.2.3. By End User (Pharmaceutical & Biotechnology Companies, Hospitals and Clinics, Academics Institutes & Research Laboratories)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Digital Pathology Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Digital Pathology Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Digital Pathology Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Digital Pathology Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Digital Pathology Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Digital Pathology Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. United Kingdom Digital Pathology Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. Italy Digital Pathology Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. France Digital Pathology Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Digital Pathology Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia-Pacific Digital Pathology Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Digital Pathology Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Digital Pathology Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Digital Pathology Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Digital Pathology Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Digital Pathology Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. South America Digital Pathology Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Digital Pathology Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Digital Pathology Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Digital Pathology Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa Digital Pathology Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Digital Pathology Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Digital Pathology Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Digital Pathology Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions

13. Global Digital Pathology Market: SWOT Analysis

14. Competitive Landscape

• 14.1. 3DHISTECH.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Corista
• 14.3. Aiforia Technologies Oy
• 14.4. Akoya Biosciences
• 14.5. OptraSCAN
• 14.6. Glencoe Software
• 14.7. QProscia Inc
• 14.8. Kanteron Systems
• 14.9. Mikroscan Technologies

15. Strategic Recommendations

16. About Us & Disclaimer